Student pricing is available for eligible university email holders. View plans

NextSprints
NextSprints Icon NextSprints Logo
Product Design

Master the art of designing products

Product Improvement

Identify scope for excellence

Product Success Metrics

Learn how to define success of product

Product Root Cause Analysis

Ace root cause problem solving

Product Trade-Off

Navigate trade-offs decisions like a pro

All Questions

Explore all questions

Meta (Facebook) PM Interview Course

Practice Meta-focused PM cases

Amazon PM Interview Course

Practice Amazon-focused PM cases

Apple PM Interview Course

Practice Apple-focused PM cases

Google PM Interview Course

Practice Google-focused PM cases

Microsoft PM Interview Course

Practice Microsoft-focused PM cases

All Courses

Explore all courses

1:1 PM Coaching

Practice in a one-to-one session

Resume Review

Narrate impactful stories via resume

Guides Pricing
nextsprints logo

Not a member?

By proceeding, you agree to our Terms of Use and confirm you have read our Privacy and Cookie Statement.

nextsprints logo

Register to continue.

Login with Google Login with LinkedIn

By proceeding, you agree to our Terms of Use and confirm you have read our Privacy and Cookie Statement .

Company focus

CoverMyMeds

Why has CoverMyMeds's ePA (electronic prior authorization) solution seen a 15% drop in provider adoption rates over the last quarter?

Prepared by NextSprints

15 mins
Report an error
Data Analysis Problem-Solving User Experience Healthcare Health Tech SaaS Product Analytics Root Cause Analysis Healthcare Tech UI/UX User Adoption
Product Management Root Cause Analysis Question: Investigating healthcare software adoption decline

Introduction

CoverMyMeds's ePA solution has experienced a 15% drop in provider adoption rates over the last quarter, signaling a critical issue that demands immediate attention. To address this problem, I'll employ a systematic approach to identify, validate, and resolve the root cause while considering both short-term fixes and long-term strategic implications.

Framework overview

This analysis follows a structured approach covering issue identification, hypothesis generation, validation, and solution development.

Step 1

Clarifying Questions (3 minutes)

  • Looking at the timing, I'm thinking there might be seasonal factors at play. Has this 15% drop been compared to the same quarter last year?

Why it matters: Seasonal variations could explain the drop and influence our solution approach. Expected answer: No significant seasonal patterns observed in previous years. Impact on approach: If seasonal, we'd focus on adapting to cyclical trends; if not, we'd investigate other factors.

  • Considering the metric specificity, I'm curious about the definition of "provider adoption rates." Has there been any recent change in how this metric is calculated or measured?

Why it matters: Ensures we're addressing a real issue, not a measurement anomaly. Expected answer: No changes in metric definition or measurement. Impact on approach: If changed, we'd need to reassess the data; if not, we proceed with root cause analysis.

  • Given the substantial drop, I'm wondering if there have been any significant product changes or updates to the ePA solution in the past quarter?

Why it matters: Recent changes could directly impact user behavior and adoption. Expected answer: A minor UI update was implemented two months ago. Impact on approach: If changes occurred, we'd focus on their impact; if not, we'd look at external factors or gradual trends.

  • Considering user segments, has the 15% drop been uniform across all provider types, or are certain segments more affected?

Why it matters: Helps focus our investigation on specific user groups or use cases. Expected answer: The drop is more pronounced among smaller healthcare practices. Impact on approach: If uniform, we'd look at system-wide issues; if segmented, we'd investigate segment-specific factors.

Subscribe to access the full answer

Image of author NextSprints

NextSprints

Updated Jan 22, 2025